Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
6.51
+0.10 (1.51%)
Jun 27, 2025, 4:00 PM - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $7.18 million as of June 27, 2025. Its market cap has decreased by -72.38% in one year.
Market Cap
7.18M
Enterprise Value
-1.42M
1-Year Change
-72.38%
Ranking
Category
Stock Price
$6.51
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $7.18M, a decrease of -94.46%. That is a compound annual growth rate of -55.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 7.08M | -34.18% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |